Loading...

Becton, Dickinson and Company

BDXNYSE
Healthcare
Medical - Instruments & Supplies
$199.66
$3.03(1.54%)

Becton, Dickinson and Company (BDX) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.9/100

Key Financials

Market Cap57.2B
P/E Ratio36.77
EPS (TTM)$5.47
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Week$168.93
1 Month$161.26
3 Months$204.73
1 Year Target$212.66

BDX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Becton, Dickinson and Company (BDX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 67.13, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $212.66.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 36.77 and a market capitalization of 57.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;